Following the recent success of our “Navigating the complexities of Market Access in Europe” workshop with the Healthcare Communications Association (HCA), we are providing another opportunity for you to get…

Currently the life-science industry’s promotional model remains disproportionately focussed on the clinical sell. It’s questionable how effective this is and pharma and devices companies continue to grapple with optimising their…

Four Regional Medicines Optimisation Committees (RMOCs) for England (London, North, South and Midlands & East) formally came into being in 2017. Their role: to provide advice and make recommendations on…